Amgen
Amgen Ventures is the corporate venture capital arm of Amgen Inc., launched in 2004 with an initial $100 million commitment to fund early-stage biotechnology and human-therapeutics companies. Focus areas include oncology, inflammation, cardiovascular disease, and neuroscience; it has invested in more than 70 companies and now manages roughly $400 million.
Thousand Oaks, United States · 60+ investments · 39 portfolio companies
- Headquarters
- Thousand Oaks, United States
- Founded
- 2004
- Website
- amgen.com
- AUM
- $200.0M
- Portfolio Companies
- 39
- Total Investments
- 60
- Last Investment
- May 2026
- Geographic Focus
- United States, Europe
Indexed holds 39 portfolio companies and 60 funding rounds for this investor. The full record is or through the API.
Investment Thesis
Amgen is a Venture Capital firm based in Thousand Oaks, United States. It has made 60 investments, including Gandeeva Therapeutics, GPB Scientific, Inc. and Immunex Corporation. Focus areas include Biotech and Digital Health.
Fund Family
Portfolio39
Co-investors24
Sign up to view co-investors
24 co-investors across 81 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×18 · Corporate VC ×4 · Sovereign Wealth Fund ×1 · 63 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/amgen"><img src="https://indexed.vc/api/badge/investor/amgen" alt="Amgen on Indexed.vc" width="260" height="76" /></a>